TABLE 4.
Anti-PyCSP antibody-treated sporozoites fail to invade livera
Mouse group used as serum source | Type of serum used to treat sporozoites | No. of P. yoelii 18S rRNA copies in livers of challenged mice (geometric mean ± SEM) |
---|---|---|
Protected | Wild-type immunized mouse sera | 2.935 ± 0.66 |
Nonprotected | Normal sera | 10,135 ± 389 |
Uninfected | 0.0665 ± 0.05 |
Naive BALB/c mice were injected with P. yoelii 17XNL sporozoites treated for 45 min with sera from rPyCSP-immunized mice that had sterilizing immunity following sporozoite challenge. Livers were harvested 40 h postchallenge for detection and quantification of the P. yoelii 18S rRNA to measure the developing liver stage parasite burden. RNA was isolated, and reverse transcription-quantitative PCR amplification for 18S RNA was performed.